metformin has been researched along with Ethmoid Sinusitis in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Ethmoid Sinusitis: Inflammation of the NASAL MUCOSA in the ETHMOID SINUS. It may present itself as an acute (infectious) or chronic (allergic) condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Savadogo, M | 1 |
| Millogo, GR | 1 |
| Zabsonré, S | 1 |
1 other study available for metformin and Ethmoid Sinusitis
| Article | Year |
|---|---|
[A hemorrhagic stroke revealing Neisseria meningitidis meningitis].
Topics: Ceftriaxone; Cerebral Hemorrhage; Emergencies; Ethmoid Sinusitis; Female; Humans; Hydrocephalus; Hyp | 2015 |